The Tour de France's controversial pre-dawn doping tests have sparked debate, with former cyclist and team boss Jonathan Vaughters weighing in. Vaughters, who rode professionally in the late 1990s and early 2000s, argues that night testing could have exposed cycling's blood-doping era earlier. He believes that testing riders at 2am is an effective method to prevent micro-dosing of substances like EPO, hGH, and testosterone, which can clear the body within hours. Vaughters' comments carry weight due to his past involvement with doping. He was a teammate of Lance Armstrong, who was later stripped of his seven Tour titles for using performance-enhancing drugs. Vaughters' team, Cannondale-EF, advocates for clean racing. However, riders like Tadej Pogačar and Jonas Vingegaard have complained about the disruption to their sleep, with Vingegaard losing about 40 minutes of sleep before a crucial mountain stage where he crashed and broke his collarbone. The International Testing Agency acknowledges the disruption but justifies night testing as necessary in limited circumstances. This debate highlights the ongoing challenge of balancing effective doping prevention with rider well-being. Vaughters' perspective offers a unique insight into the potential benefits of night testing, but the practical implications and rider safety concerns remain a complex issue.
